Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10012535285
Persistent link: https://www.econbiz.de/10012273082
Persistent link: https://www.econbiz.de/10012406859
An understanding of the relationship between cost sharing and drug consumption depends on consistent and unbiased price elasticity estimates. However, there is wide heterogeneity among studies, which constrains the applicability of elasticity estimates for empirical purposes and policy...
Persistent link: https://www.econbiz.de/10005792879
The Technological Change in Health Care Research Network collected unique patient-level data on three procedures for treatment of heart attack patients (catheterization, coronary artery bypass grafts and percutaneous transluminal coronary angioplasty) for 17 countries over a 15-year period to...
Persistent link: https://www.econbiz.de/10008542732
Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. <P>Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of...</p>
Persistent link: https://www.econbiz.de/10008643996
Persistent link: https://www.econbiz.de/10008644003
Persistent link: https://www.econbiz.de/10010638661
Perceived quality of private and public health care, income and insurance premium are among the determinants of demand for private health insurance (PHI). In the context of a model in which individuals are expected utility maximizers, the non purchasing choice can result in consuming either...
Persistent link: https://www.econbiz.de/10005199997
One of the limitations of cross-country health expenditure analysis refers to the fact that the financing, the internal organization and political restraints of health care decision-making are country-specific and heterogeneous. Yet, a way through is to examine the influence of such effects in...
Persistent link: https://www.econbiz.de/10005792793